AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H1858-H1864, 2005. First published June 3, 2005; doi:10.1152/ajpheart.00216.2005
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/5/H1858    most recent
00216.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsusaka, H.
Right arrow Articles by Tsutsui, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsusaka, H.
Right arrow Articles by Tsutsui, H.

Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy

Hidenori Matsusaka,1 Masaki Ikeuchi,1 Shouji Matsushima,1 Tomomi Ide,1 Toru Kubota,1 Arthur M. Feldman,2 Akira Takeshita,1 Kenji Sunagawa,1 and Hiroyuki Tsutsui3

1Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka; 3Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan; and 2Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania

Submitted 7 March 2005 ; accepted in final form 23 May 2005

Tumor necrosis factor-{alpha} (TNF-{alpha}) plays a pathophysiological role in the development and progression of heart failure. Matrix metalloproteinase (MMP)-2 is involved in extracellular matrix remodeling. Recent evidence suggests a protective role for this protease against tissue inflammation. Although MMP-2 is upregulated in the failing heart, little is known about its pathophysiological role. We thus hypothesized that ablation of the MMP-2 gene could affect cardiac remodeling and failure in TNF-{alpha}-induced cardiomyopathy. We crossed transgenic mice with cardiac-specific overexpression of TNF-{alpha} (TG) with MMP-2 knockout (KO) mice. Four groups of male and female mice were studied: wild-type (WT) with wild MMP-2 (WT/MMP+/+), WT with MMP-2 KO (WT/MMP–/–), TNF-{alpha} TG with wild MMP-2 (TG/MMP+/+), and TG with MMP-2 KO (TG/MMP–/–). The upregulation of MMP-2 zymographic activity in TG/MMP+/+ mice was completely abolished in TG/MMP–/– mice, and other MMPs and tissue inhibitors of metalloproteinase were comparable between groups. Survival was shorter for male TG/MMP–/– than TG/MMP+/+ mice. Female TG/MMP–/– mice were more severely affected than TG/MMP+/+ mice with diminished cardiac function. Myocardial TNF-{alpha} and other proinflammatory cytokines were increased in TG/MMP+/+ mice, and this increase was similarly observed in TG/MMP–/– mice. The extent of myocardial infiltrating cells including macrophages was greater in TG/MMP–/– than in TG/MMP+/+ mice. Selective ablation of the MMP-2 gene reduces survival and exacerbates cardiac failure in association with the increased level of myocardial inflammation. MMP-2 may play a cardioprotective role in the pathogenesis of cytokine-induced cardiomyopathy.

metalloproteinases; heart failure; tumor necrosis factor



Address for reprint requests and other correspondence: H. Tsutsui, Dept. of Cardiovascular Medicine, Hokkaido Univ. Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060-8638, Japan (E-mail: htsutsui{at}med.hokudai.ac.jp)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Bergman, J. R. Teerlink, R. Mahimkar, L. Li, B.-Q. Zhu, A. Nguyen, S. Dahi, J. S. Karliner, and D. H. Lovett
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1847 - H1860.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. Marsolais, E. Duchesne, C. H. Cote, and J. Frenette
Inflammatory cells do not decrease the ultimate tensile strength of intact tendons in vivo and in vitro: protective role of mechanical loading
J Appl Physiol, January 1, 2007; 102(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Matsusaka, T. Ide, S. Matsushima, M. Ikeuchi, T. Kubota, K. Sunagawa, S. Kinugawa, and H. Tsutsui
Targeted Deletion of Matrix Metalloproteinase 2 Ameliorates Myocardial Remodeling in Mice With Chronic Pressure Overload
Hypertension, April 1, 2006; 47(4): 711 - 717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.